Cargando…
Recommendations for the use of bioresorbable vascular scaffolds in percutaneous coronary interventions: 2017 revision
BACKGROUND: To eliminate some of the potential late limitations of permanent metallic stents, the bioresorbable coronary stents or ‘bioresorbable vascular scaffolds’ (BVS) have been developed. METHODS: We reviewed all currently available clinical data on BVS implantation. RESULTS: Since the 2015 pos...
Autores principales: | Everaert, B., Wykrzykowska, J. J., Koolen, J., van der Harst, P., den Heijer, P., Henriques, J. P., van der Schaaf, R., de Smet, B., Hofma, S. H., Diletti, R., Weevers, A., Hoorntje, J., Smits, P., van Geuns, R. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bohn Stafleu van Loghum
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513994/ https://www.ncbi.nlm.nih.gov/pubmed/28643297 http://dx.doi.org/10.1007/s12471-017-1014-z |
Ejemplares similares
-
Appropriate use of bioresorbable vascular scaffolds in percutaneous coronary interventions: a recommendation from experienced users: A position statement on the use of bioresorbable vascular scaffolds in the Netherlands
por: Everaert, Bert, et al.
Publicado: (2015) -
Three‐year clinical outcomes of the absorb bioresorbable vascular scaffold compared to Xience everolimus‐eluting stent in routine PCI in patients with diabetes mellitus—AIDA sub‐study
por: Kerkmeijer, Laura S.M., et al.
Publicado: (2020) -
Current status of clinically available bioresorbable scaffolds in percutaneous coronary interventions
por: Felix, Cordula, et al.
Publicado: (2015) -
The 2010s in clinical drug-eluting stent and bioresorbable scaffold research: a Dutch perspective
por: Kawashima, H., et al.
Publicado: (2020) -
Conformability in everolimus-eluting bioresorbable scaffolds compared with metal platform coronary stents in long lesions
por: Fam, Jiang Ming, et al.
Publicado: (2017)